T. Sasada et al., REDOX CONTROL OF RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM-(II) (CDDP) - PROTECTIVE EFFECT OF HUMAN THIOREDOXIN AGAINST CDDP-INDUCED CYTOTOXICITY, The Journal of clinical investigation, 97(10), 1996, pp. 2268-2276
Thioredoxin is a small ubiquitous protein with multiple biological fun
ctions, including cellular defense mechanisms against oxidative stress
. In the present study, we investigated the role of human thioredoxin
(hTRX) in the acquisition of cellular resistance to cis-diamminedichlo
roplatinum (II) (CDDP). The expression and activity of hTRX in Jurkat
T cells was dose-dependently enhanced by exposure to CDDP, as determin
ed by immunoblot analysis and insulin reducing assay. Furthermore, chl
oramphenicol acetyltransferase analysis using the hTRX promoter-report
er gene construct revealed that treatment of Jurkat cells with CDDP ca
used transcriptional activation of the hTRX gene, which might be media
ted through increased generation of intracellular reactive oxygen inte
rmediates. To examine the biological significance of hTRX induction, w
e established hTRX-overexpressing derivatives of L929 fibrosarcoma cel
ls by stable transfection with the hTRX cDNA. The clones, which consti
tutively expressed the exogenous hTRX, displayed increased resistance
to CDDP-induced cytotoxicity, compared with the control clones. After
exposure to CDDP, the control cells showed a significant increase in t
he intracellular accumulation of peroxides, whereas the hTRX-transfect
ed cells did not. Taken together, these results suggest that overexpre
ssed hTRX is responsible for the development of cellular resistance to
CDDP, possibly by scavenging intracellular toxic oxidants generated b
y this anticancer agent.